IL21R and systemic lupus erythematosus: Similarly, administration of an IL-21R-Fc fusion protein to BXSB.B6-Yaa+/J mice, the second SLE animal model, decreased IL-21 production, lymphocyte activation and circulating IgG1 levels [27].